Kenneth Tang

Array ( [id] => 17050681 [patent_doc_number] => 20210260115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => MODIFIED NATURAL KILLER CELLS, PHARMACEUTICAL COMPOSITION, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/797550 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17037043 [patent_doc_number] => 20210254001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => FcyRIIIa signaling generates Bcl6+PD1+CD4+ Tfh-like cells [patent_app_type] => utility [patent_app_number] => 16/792204 [patent_app_country] => US [patent_app_date] => 2020-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16792204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17518634 [patent_doc_number] => 20220104482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => Compositions, Methods and Kits for Stabilizing Cells and Biological Samples [patent_app_type] => utility [patent_app_number] => 17/428453 [patent_app_country] => US [patent_app_date] => 2020-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -81 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16391321 [patent_doc_number] => 20200332262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-22 [patent_title] => RE-AGGREGATION OF STEM CELL-DERIVED PANCREATIC BETA CELLS [patent_app_type] => utility [patent_app_number] => 16/748395 [patent_app_country] => US [patent_app_date] => 2020-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17414321 [patent_doc_number] => 20220049225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => CELL COMPOSITION COMPRISING LIVER PROGENITOR CELLS EXPRESSING HLA-E [patent_app_type] => utility [patent_app_number] => 17/312768 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17441833 [patent_doc_number] => 20220062338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => PSCA CAR-T CELLS [patent_app_type] => utility [patent_app_number] => 17/312901 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52142 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17227117 [patent_doc_number] => 20210353673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => CD11B + PIEZO-1 + MACROPHAGES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/284449 [patent_app_country] => US [patent_app_date] => 2019-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15650195 [patent_doc_number] => 20200087627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-19 [patent_title] => METHODS OF EXTRACTING HEMATOPOIETIC CELLS FROM BONE MARROW EX VIVO [patent_app_type] => utility [patent_app_number] => 16/574893 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16574893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17167936 [patent_doc_number] => 20210321606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => METHOD FOR OBTAINING AN ENRICHED POPULATION OF FUNCTIONAL MESENCHYMAL STEM CELLS, CELLS OBTAINED THEREOF AND COMPOSITIONS AND COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 17/276340 [patent_app_country] => US [patent_app_date] => 2019-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17385914 [patent_doc_number] => 20220033766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => ANTIGEN-SPECIFIC T LYMPHOCYTES AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/274943 [patent_app_country] => US [patent_app_date] => 2019-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15590265 [patent_doc_number] => 20200071667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => COMPOSITION COMPRISING GLYCYRRHIZIN FOR INDUCING DIFFERENTIATION INTO MYELOID-DERIVED SUPPRESSOR CELL FROM MYELOID CELL [patent_app_type] => utility [patent_app_number] => 16/557912 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15206273 [patent_doc_number] => 20190365823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => ENCAPSULATED INTESTINAL MIDGUT ENDODERM CELLS [patent_app_type] => utility [patent_app_number] => 16/540657 [patent_app_country] => US [patent_app_date] => 2019-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13059 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16540657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17274810 [patent_doc_number] => 20210381008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => METHOD FOR PRODUCING FOREIGN ANTIGEN RECEPTOR GENE-INTRODUCED CELL [patent_app_type] => utility [patent_app_number] => 17/262400 [patent_app_country] => US [patent_app_date] => 2019-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19130 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15039157 [patent_doc_number] => 20190330583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => Vascularized In Vitro Perfusion Devices, Methods of Fabricating, and Applications Thereof [patent_app_type] => utility [patent_app_number] => 16/458305 [patent_app_country] => US [patent_app_date] => 2019-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16458305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15267987 [patent_doc_number] => 20190382727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => CULTURE MEDIA FOR SIMULTANEOUS TESTING OF MULTIPLE HEMATOPOIETIC DISEASE TYPES [patent_app_type] => utility [patent_app_number] => 16/438507 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16990207 [patent_doc_number] => 20210228627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => FUSOSOME COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/055077 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70606 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19563532 [patent_doc_number] => 12138283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => Method of preparing three-dimensional cell spheroid including adipose-derived stem cells and hepatocytes [patent_app_type] => utility [patent_app_number] => 16/413278 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7823 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16413278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14778549 [patent_doc_number] => 20190264172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => METHOD OF OBTAINING TERMINALLY DIFFERENTIATED NEURONAL LINEAGES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/410516 [patent_app_country] => US [patent_app_date] => 2019-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16410516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16808231 [patent_doc_number] => 20210130784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR STIMULATION OF DISC REGENERATION [patent_app_type] => utility [patent_app_number] => 17/052841 [patent_app_country] => US [patent_app_date] => 2019-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17126484 [patent_doc_number] => 20210301252 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2021-09-30 [patent_title] => METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS [patent_app_type] => utility [patent_app_number] => 16/382071 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25568 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382071 [rel_patent_id] =>[rel_patent_doc_number] =>)